The science
June 2026The biofilm–inflammation connection: why the fortress is the real enemy
“If C. acnes lives on everyone, what actually makes it inflammatory?”
For two decades, acne was framed as a numbers game: too much Cutibacterium acnes, too much inflammation. The contemporary evidence tells a different story. The thing that actually drives inflammation is not the free-floating bacterium but the biofilm — a matrix-encased, lipid-fed, oxygen-starved community that behaves like a fortress. Understanding that shift changes what good treatment should even try to do.
In one sentence
In its biofilm state, C. acnes concentrates its virulence, evades the immune system and tolerates antibiotics — so the inflammatory unit is the organised fortress, not the individual cell; dismantling the fortress matters more than counting its occupants, and how you dismantle it may decide whether inflammation settles or briefly flares.
How C. acnes builds its fortress
The switch from free-swimming to fortified is not random. It is induced by three conditions that converge inside a plugged follicle. First, the low-oxygen pocket: once the pore seals, the space turns anoxic, which favours C. acnes over its aerobic neighbours and reprograms it toward making porphyrins — the very molecules that later trip the immune alarm. Second, the oil supply: acne-type sebum (high triglyceride, oxidised squalene, low linoleic acid, high palmitic acid) selects for the virulent IA1 lineage. Third, the pore traffic jam: retained, sticky skin cells form the microcomedo, and the biofilm matrix then acts as a glue that compacts the plug.
Host signals fine-tune the timing. Stress-associated catecholamines and natriuretic peptides nudge the follicular community toward biofilm — so the bacterium’s lifestyle is shaped by its environment, not chosen at random.
Seven molecular weapons
Once built, the fortress deploys a convergent arsenal. Independent studies map these weapons onto the same handful of inflammatory nodes — the TLR2/4 ‘smoke detectors’, the NLRP3 ‘alarm amplifier’, the IL-1β / IL-8 / IL-17 ‘alarm messengers’, porphyrin ‘irritant by-products’, the CAMP ‘bacterial toxin’, ‘oil-splitting’ lipases, and the ‘tissue-loosening’ hyaluronate lyase.
The decisive point is that they interlock rather than fire alone: porphyrins and CAMP pores both drive the potassium efflux that powers the inflammasome; lipase-made fatty acids both clog and inflame; tissue fragments and CAMP both feed TLR2. The redundancy is exactly why the biofilm is so reliably inflammatory.
Remember this
Biofilm-derived C. acnes activates the inflammatory machinery of skin cells robustly; the same cells, free-swimming, under identical conditions largely do not. State — not headcount — decides pathogenicity.
A different beast: fortified and ferocious
Why is the biofilm state so much more dangerous? It tolerates antibiotics structurally, not just genetically: the matrix is a physical barrier and its slow, dormant cells offer few targets, with a polymer called PNAG conferring tolerance to benzoyl peroxide and tetracycline. It evades immunity, shielding surface antigens behind an extracellular-DNA scaffold. And it is the actual virulence unit — acne-associated IA1 strains build thicker, more biomass-rich fortresses with far higher biofilm-specific tolerance.
Crucially, biofilm tolerance is distinct from genetic resistance — a strain can be one without being the other — which is why stripping the matrix re-sensitises the community.
Structural tolerance
A wall, not a mutation
The matrix barrier and dormant metabolism resist drugs that target active growth — tolerance that vanishes when the community disperses.
Immune evasion
Hidden behind the matrix
The eDNA scaffold shields antigens from complement and immune cells, letting IA1 strains build larger fortresses than commensals.
The virulence unit
The community, not the cell
It is the organised biofilm that triggers keratinocyte inflammation — the single planktonic cell does not.
It’s not about total bacteria count
The single most important fact in modern acne microbiology is a negative result: total C. acnes is broadly similar on acne-prone and healthy skin. What differs is organisation — a collapse in microbiome diversity, IA1 dominance and biofilm frequency. The local overgrowth seen inside a lesion looks more like a consequence of inflammation than its cause.
There is an honest nuance worth keeping: some evidence suggests biofilm first stabilises a quiet comedone, and the decisive inflammatory event is the transition to a ruptured follicle. So biofilm burden is a far better correlate of inflammatory acne than headcount — but the precise tipping point is still an open question.
Break it, and the inflammation subsides
If the biofilm is the problem, dismantling it should resolve inflammation — and the evidence is encouraging, if thinner than the mechanism deserves. In the lab, stripping the matrix turns a tolerant biofilm into an easily cleared one within minutes. In people, a sustained biofilm-disrupting topical showed measurable improvement from around week six, strengthening through week twenty-four.
Two caveats matter. These studies measured lesions and severity grades, not cytokines — no human study has yet tracked the molecular alarm signals switching off after a biofilm-targeted treatment. And the strongest dataset was industry-funded and modest in size. Improvement on a scale of weeks fits the hypothesis; the molecular proof that would close the loop is still missing.
Why killing isn’t enough
Here is the most consequential, least settled question in this field. Killing bacteria and dissolving a matrix are not clean events — they liberate cargo. The acne biofilm matrix is an inventory of immunologically active material: polysaccharides, proteins, inflammatory eDNA, porphyrins and a battery of enzymes. Disrupt the community and leave the debris in place, and you release that whole payload at once.
From other fields, the principle is established: the manner of killing shapes the inflammatory aftermath, and lytic killing that floods tissue with bacterial fragments can transiently worsen inflammation. By extension, a strategy that kills and abandons its lysate could, in principle, sustain a flare rather than settle it.
An honest note on the evidence
No acne study has yet directly compared disruption with the lysate left in place versus rinsed away, or measured cytokines across that contrast. The concern is biologically credible but remains a hypothesis. Reassuringly, a leave-on biofilm-disrupting cream improved rather than worsened outcomes — so any release effect is unlikely to dominate in mild-to-moderate disease. The defensible position: disperse-and-remove is theoretically preferable to kill-and-abandon, and the head-to-head trial is exactly what the field needs.
| The old picture | The modern science |
|---|---|
| Too much C. acnes | The biofilm is the inflammatory unit |
| More bacteria, more acne | Organisation and strain, not headcount |
| Resistance is genetic | Biofilm tolerance is structural and reversible |
| Just kill the bacteria | Dismantle the fortress — cleanly |
The shift to remember
The therapeutic question is no longer how many bacteria to kill, but how to dismantle the fortress — cleanly. Defeat the structure, not the census.
Selected references
- Coenye et al. 2021, Biofilm — the role of biofilm formation in the pathogenesis and antimicrobial susceptibility of C. acnes
- Mayslich et al. 2021, Microorganisms — C. acnes as an opportunistic pathogen and its virulence factors
- Zeng et al. 2019, J Invest Dermatol — miR-146a and biofilm-derived C. acnes-induced keratinocyte inflammation
- Spittaels et al. 2021, iScience — porphyrins from acneic C. acnes activate the inflammasome via K+ leakage
- Kistowska et al. 2014, J Invest Dermatol — C. acnes induces IL-1β via the NLRP3 inflammasome
- Chen et al. 2025, Microbial Genomics — C. acnes CAMP factor interactions in acne vulgaris
- Cavallo et al. 2022, Scientific Reports — skin dysbiosis and C. acnes biofilm in inflammatory acne lesions
- Platsidaki & Dessinioti 2018, F1000Research — recent advances in understanding C. acnes in acne
- Kaplan et al. 2025, PLOS ONE — dispersin B and benzoyl peroxide synergy against C. acnes biofilm
- Gannesen et al. 2019, Front Microbiol — composition of the C. acnes biofilm matrix (strain RT5)
- Nau & Eiffert 2002, Clin Microbiol Rev — antibacterial-induced release of proinflammatory bacterial compounds
- O’Neill & Gallo 2018, Microbiome — host–microbiome interactions and the biology of acne vulgaris
This explainer builds on a Consensus.ai synthesis of C. acnes biofilm and the inflammatory cascade in acne, enriched and fact-checked against current peer-reviewed sources (2015–2026). Full citations with DOIs are in the downloadable booklet, where each claim is graded as strong, moderate or preliminary. Educational content — not medical advice or product claims.